Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 242 | 1,096 | 0 | 75 | 148 |
| Gross Profit | 242 | 1,096 | N/A | 75 | 148 |
| Operating Expenses | 3,040 | 3,475 | 4,173 | 4,215 | 3,475 |
| Operating Income | -2,798 | -2,379 | -4,173 | -4,140 | -3,327 |
| Other Income | 18 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,780 | -2,379 | -4,173 | -4,140 | -3,327 |
| Net Income Continuous | -2,780 | -2,379 | -2,831 | -4,140 | -3,327 |
| Net Income | $-2,780 | $-2,379 | $-2,831 | $-4,140 | $-3,327 |
| EPS Basic Total Ops | -377.85 | -755.70 | -701.72 | -1,295.48 | -1,511.40 |
| EPS Basic Continuous Ops | -400.37 | -744.23 | -708.96 | -1,298.99 | -1,488.18 |
| EPS Diluted Total Ops | -377.85 | -755.70 | -701.72 | -1,295.48 | -1,511.40 |
| EPS Diluted Continuous Ops | -400.37 | -744.23 | -708.96 | -1,298.99 | -1,488.18 |
| EBITDA(a) | $-2,790 | $-2,371 | $-4,167 | $-4,136 | $-3,322 |